GEODE CAPITAL MANAGEMENT, LLC - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 91 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2017. The put-call ratio across all filers is 2.40 and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q2 2019$206,000
-73.3%
430,465
-25.2%
0.00%
Q1 2019$771,000
-38.1%
575,673
-47.8%
0.00%
Q4 2018$1,246,000
-14.8%
1,103,674
+108.2%
0.00%
Q3 2018$1,462,000
-19.5%
529,983
+4.1%
0.00%
-100.0%
Q2 2018$1,816,000
+36.4%
508,907
+17.3%
0.00%
Q1 2018$1,331,000
-50.6%
433,727
+1.4%
0.00%
-100.0%
Q4 2017$2,694,000
-6.5%
427,767
+1.5%
0.00%0.0%
Q3 2017$2,881,000
+25.6%
421,269
+31.0%
0.00%0.0%
Q2 2017$2,293,000
-20.4%
321,676
+2.6%
0.00%0.0%
Q1 2017$2,880,000
+166.9%
313,390
+17.0%
0.00%0.0%
Q4 2016$1,079,000
+8.1%
267,836
+2.8%
0.00%0.0%
Q3 2016$998,000
-9.5%
260,648
+1.6%
0.00%0.0%
Q2 2016$1,103,000
+2.2%
256,630
+10.0%
0.00%0.0%
Q1 2016$1,079,000
-53.5%
233,255
+0.7%
0.00%0.0%
Q4 2015$2,322,000
+37.2%
231,542
+2.1%
0.00%0.0%
Q3 2015$1,692,000
-84.3%
226,849
-0.0%
0.00%
-83.3%
Q2 2015$10,761,000
+40.1%
226,850
+8.2%
0.01%
+50.0%
Q1 2015$7,681,000
+11.8%
209,659
+21.2%
0.00%0.0%
Q4 2014$6,870,000
+284.7%
173,010
+93.2%
0.00%
+300.0%
Q3 2014$1,786,000
+52.8%
89,534
+3.3%
0.00%0.0%
Q2 2014$1,169,000
+30.8%
86,680
+5.5%
0.00%0.0%
Q1 2014$894,000
-9.9%
82,182
+11.9%
0.00%0.0%
Q4 2013$992,000
+81.7%
73,414
+53.1%
0.00%
Q3 2013$546,000
+87.6%
47,942
+15.8%
0.00%
Q2 2013$291,00041,3930.00%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q2 2017
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 664,000$2,543,0000.82%
GREAT POINT PARTNERS LLC 452,375$1,733,0000.44%
Clearline Capital LP 267,915$1,026,0000.32%
Rhenman & Partners Asset Management AB 300,000$1,149,000,0000.18%
Rock Springs Capital Management LP 662,500$2,537,0000.16%
Eventide Asset Management 600,000$2,298,0000.14%
Granahan Investment Management 657,496$2,518,0000.08%
Candriam S.C.A. 374,000$1,432,0000.03%
Tekla Capital Management LLC 192,322$737,0000.03%
DOW CHEMICAL CO /DE/ 65,000$249,0000.02%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders